Source: European Archives of Psychiatry and Clinical Neuroscience. Unidades: EERP, FMRP
Subjects: ALUCINOGÊNICOS, USO DE MEDICAMENTOS, ALCALOIDES
ABNT
ROCHA, Juliana Mendes et al. Identifying setting factors associated with improved ibogaine safety: a systematic review of clinical studies. European Archives of Psychiatry and Clinical Neuroscience, v. 273, n. 7, p. 1527-1542, 2023Tradução . . Disponível em: https://doi.org/10.1007/s00406-023-01590-1. Acesso em: 09 out. 2024.APA
Rocha, J. M., Reis, J. A. S., Bouso, J. C., Hallak, J. E. C., & Santos, R. G. dos. (2023). Identifying setting factors associated with improved ibogaine safety: a systematic review of clinical studies. European Archives of Psychiatry and Clinical Neuroscience, 273( 7), 1527-1542. doi:10.1007/s00406-023-01590-1NLM
Rocha JM, Reis JAS, Bouso JC, Hallak JEC, Santos RG dos. Identifying setting factors associated with improved ibogaine safety: a systematic review of clinical studies [Internet]. European Archives of Psychiatry and Clinical Neuroscience. 2023 ; 273( 7): 1527-1542.[citado 2024 out. 09 ] Available from: https://doi.org/10.1007/s00406-023-01590-1Vancouver
Rocha JM, Reis JAS, Bouso JC, Hallak JEC, Santos RG dos. Identifying setting factors associated with improved ibogaine safety: a systematic review of clinical studies [Internet]. European Archives of Psychiatry and Clinical Neuroscience. 2023 ; 273( 7): 1527-1542.[citado 2024 out. 09 ] Available from: https://doi.org/10.1007/s00406-023-01590-1